NASDAQ : VANI
Vivani Medical, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 1.14 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 102.83M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 100.13M |
| Enterprise Value | 98.09M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 90.20M |
| Shares Outstanding | 90.20M |
| Shares Change (YoY) | +29.54% |
| Shares Change (QoQ) | +7.16% |
| Owned by Insiders (%) | 49.89% |
| Owned by Institutions (%) | 7.04% |
| Float | 38.94M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.14 |
| P/TBV Ratio | 5.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.25 |
| Quick Ratio | 3.09 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -220.40% |
| Return on Assets (ROA) | -48.48% |
| Return on Invested Capital (ROIC) | -56.66% |
| Return on Capital Employed (ROCE) | -78.21% |
| Weighted Average Cost of Capital (WACC) | 19.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$626,500 |
| Employee Count | 42 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 3.30 |
| 52-Week Price Change | -38.42% |
| 50-Day Moving Average | 1.25 |
| 200-Day Moving Average | 1.26 |
| Relative Strength Index (RSI) | 35.97 |
| Average Volume (20 Days) | 175,961 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 417,148 |
| Short Previous Month | 519,687 |
| Short % of Shares Out | 0.46% |
| Short % of Float | 1.07% |
| Short Ratio (days to cover) | 2.33 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -27.36M |
| Pretax Income | -26.31M |
| Net Income | -26.31M |
| EBITDA | -26.88M |
| EBIT | -27.36M |
| Earnings Per Share (EPS) | -$0.35 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 19.89M |
| Total Debt | 17.86M |
| Net Cash | 2.04M |
| Net Cash Per Share | $0.02 |
| Equity (Book Value) | 18.97M |
| Book Value Per Share | 0.21 |
| Working Capital | 14.98M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -25.30M |
| Capital Expenditures | -1.20M |
| Depreciation & Amortization | 478,000 |
| Net Borrowing | 35,000 |
| Free Cash Flow | -26.50M |
| FCF Per Share | -$0.29 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -29.54% |
| Shareholder Yield | -29.54% |
| Earnings Yield | -31.66% |
| FCF Yield | -25.59% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $3.83 |
| Price Target Difference | 245.32% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |